日本語English简体中文 繁體中文

301263 Guangdong Taienkang Pharmaceutical Co., Ltd.泰恩康Shenzhen Stock Exchange

8 posts

Guangdong Taienkang Pharmaceutical Co., Ltd. (301263) at a glance

Code
301263
Company
Guangdong Taienkang Pharmaceutical Co., Ltd.
Local name
泰恩康
Market
Shenzhen Stock Exchange
Share price
CN¥17.92 +0.14 (+0.79%) Oct 16 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Guangdong Taienkang Pharmaceutical Co., Ltd. (301263) share price over the last 3 months

Over the last 3 months (Jul 16 – Oct 16), Guangdong Taienkang Pharmaceutical Co., Ltd. traded between a high of CN¥21.79 (Sep 23) and a low of CN¥17.78 (Oct 15). It closed at CN¥17.92 on Oct 16, −17.5% from 3 months ago and −10.1% from a month ago.

High CN¥21.79Low CN¥17.78Jul 16Oct 16
3-month highCN¥21.79Sep 23
3-month lowCN¥17.78Oct 15
vs 1 month ago−10.1%vs Sep 9
vs 3 months ago−17.5%vs Jul 16

Closing prices, last 10 trading days

DateCloseChange% Change
Oct 16 (Fri)CN¥17.92+0.14+0.79%
Oct 15 (Thu)CN¥17.78−0.60−3.26%
Oct 14 (Wed)CN¥18.38−0.07−0.38%
Oct 13 (Tue)CN¥18.45−0.45−2.38%
Oct 12 (Mon)CN¥18.90−0.24−1.25%
Oct 9 (Fri)CN¥19.14+0.62+3.35%
Oct 8 (Thu)CN¥18.52−0.57−2.99%
Sep 30 (Wed)CN¥19.09+0.02+0.10%
Sep 29 (Tue)CN¥19.07+0.27+1.44%
Sep 28 (Mon)CN¥18.80−1.01−5.10%

Daily closing prices from Yahoo! Finance. Always check the latest price before trading.

Recent announcements (CNINFO, in Chinese)

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No.8 Disclosure 2026/10/16 09:00
新薬・製品の承認
关于全资子公司收到聚多卡醇注射液药品注册证书的公告
Delete
No.7 Disclosure 2026/10/15 09:00
保有株の担保差入
关于控股股东、实际控制人部分股份解除质押的公告
Delete
No.6 Disclosure 2026/10/09 09:00
新薬・製品の承認
关于全资子公司收到地夸磷索钠滴眼液药品注册证书的公告
Delete
No.5 Disclosure 2026/10/08 09:00
保有株の担保差入
关于控股股东、实际控制人部分股份质押的公告
Delete
No.4 Disclosure 2026/09/23 09:00
新薬・製品の承認
关于控股子公司CKBA乳膏玫瑰痤疮适应症获得IIa期临床试验研究初步分析结果的公告
Delete
No.3 Disclosure 2026/09/22 09:00
従業員持株
关于2025年员工持股计划锁定期届满的提示性公告
Delete
No.2 Disclosure 2026/09/21 09:00
新薬・製品の承認
关于全资子公司收到盐酸拉贝洛尔片药品注册证书的公告
Delete
No.1 Disclosure 2026/09/17 09:00
自社株買い
关于回购公司股份实施结果暨股份变动的公告
Delete

Write on the Guangdong Taienkang Pharmaceutical Co., Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English